Vitamin A for Vision / Eye Health

Verdict: Essential for deficiency, not general eye health

Vitamin A reliably reverses night blindness and dry-eye damage (xerophthalmia) caused by genuine deficiency, but for well-nourished adults it does not improve general vision or prevent age-related eye disease, and high doses or beta-carotene carry real harms.

B 🟡 B Preliminary Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The evidence splits cleanly by population. In people who are actually deficient, it is strong: Sommer's 1983 Indonesian cohort (PMID 6136744) linked mild xerophthalmia to sharply higher child mortality and showed night blindness and Bitot's spots reverse after repletion, and the Cochrane review of 47 trials (PMID 28282701, ~1.2 million children) found supplementation cut all-cause mortality about 12% (RR 0.88) and night blindness by roughly two-thirds (RR ~0.32). A maternal trial in deficient Bangladeshi women (PMID 10024613) showed the same reversal of night blindness.

Regulators and clinics confirm only this narrow benefit. WHO strongly recommends supplementation for children 6–59 months solely where deficiency is a public-health problem, while NIH ODS and the Cleveland Clinic describe night blindness as an early deficiency sign that vitamin A corrects. None endorse routine supplements for well-nourished adults, and EFSA's authorized claim covers only "maintenance of normal vision," not improvement.

The grade is held at preliminary because the benefit does not generalize and there are documented harms. AREDS2 (PMID 23644932) dropped beta-carotene, a vitamin A precursor, from its eye formula after it raised lung-cancer risk in former smokers, echoing CARET (PMID 8602180; lung-cancer RR 1.28, mortality RR 1.17 in smokers); the American Academy of Ophthalmology cites exactly this. The UK NHS also warns against retinol supplements in pregnancy because of birth-defect risk. For most replete adults seeking sharper vision, vitamin A is unproven and unsafe at high doses.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.71
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
90%
Highly consistent evidence
Evidence level
E1
Cochrane high-quality SR/MA

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.62
L11 AI re-checkIndependent read
0.65
L3 MechanismPlausibility
0.75
L2 PubMedPrimary literature
0.85
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.712
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — A 級條件未達 (需 E1-E3 + L5≥2 supportive + L4 無 against;實際 E1 / L5=1 / L4_against=0)
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Increased mortality in children with mild vitamin A deficiency
PMID: 6136744 1983 Other n = 3,481
Finding: Children with mild xerophthalmia had markedly higher mortality than non-deficient peers, and night blindness / Bitot's spots reversed rapidly after vitamin A repletion. This is the landmark Sommer-Indonesia evidence establishing vitamin A as essential treatment for xerophthalmia and night blindness in deficient populations. NOT an RCT — observational mortality + clinical reversal data.
Academic Effect size: Relative risk of mortality substantially elevated in xerophthalmic group (qualitative; large effect)
View on PubMed
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age (Cochrane Review)
PMID: 28282701 2017 系統性回顧 n = 1,202,382
Finding: Vitamin A supplementation reduces all-cause mortality by approximately 12% (RR 0.88, 95% CI 0.83 to 0.93) and substantially reduces the incidence of night blindness (RR ~0.32) and Bitot's spots in children at risk of deficiency. Strong, high-quality evidence for vision-related deficiency outcomes (night blindness, xerophthalmia) in deficient populations. Does NOT support routine use in vitamin-A-replete populations.
🟢 High quality Academic Effect size: Mortality RR 0.88 (0.83-0.93); night blindness RR ~0.32; Bitot's spots RR ~0.42
View on PubMed
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial
PMID: 23644932 2013 隨機對照試驗 n = 4,203
Finding: Beta-carotene (the vitamin A precursor in original AREDS) was REMOVED from the recommended AREDS2 formula because it significantly increased lung cancer incidence in former smokers (HR ~2.0). Lutein + zeaxanthin substituted as the safer carotenoid alternative. AREDS2 thus represents an explicit guideline-level shift AWAY from vitamin-A-precursor supplementation for AMD. This trial concerns AMD, not general vision, but is the most-cited reason vitamin A / beta-carotene is NOT recommended for adult eye health.
🟢 High quality Government Effect size: Beta-carotene arm: lung cancer HR ~2.0 in former smokers; no benefit over lutein/zeaxanthin for AMD progression
View on PubMed
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease (CARET)
PMID: 8602180 1996 隨機對照試驗 n = 18,314
Finding: CARET was halted early because the beta-carotene + vitamin A arm showed a 28% increase in lung cancer incidence and 17% increase in all-cause mortality vs placebo in current smokers / asbestos-exposed workers. This is the foundational safety signal that, together with ATBC (Finnish smokers trial), drove the AREDS2 decision to drop beta-carotene. Directly relevant when framing vitamin A for vision: oral high-dose vitamin A / beta-carotene supplementation carries documented harm in smokers.
🟢 High quality Government Effect size: Lung cancer RR 1.28 (1.04-1.57); all-cause mortality RR 1.17 (1.03-1.33)
View on PubMed
Maternal vitamin A or beta-carotene supplementation in lactating bangladeshi women benefits mothers and infants but does not prevent subclinical deficiency
PMID: 10024613 1999 隨機對照試驗 n = 226
Finding: In vitamin-A-deficient lactating women, supplementation improved breast milk retinol and reduced maternal night blindness incidence. Reinforces the deficiency-treatment paradigm: vitamin A reverses night blindness when populations are deficient. Does not establish benefit in replete populations.
Academic Effect size: Reduction in maternal night blindness; significant improvement in milk retinol vs placebo
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Vitamin A — GRAS — 21 CFR 184.1245, 184.1930 — Technical Effect: NUTRIENT SUPPLEMENT — SCOGS no. 118 source↗
L4b EU EFSA
Neutral
Vitamin A contributes to the normal function of the immune system; Vitamin A contributes to the maintenance of normal vision; Vitamin A contributes to the maintenance of normal skin; Vitamin A contributes to the maintenance of normal mucous membranes; Vitamin A has a role in the process of cell specialisation; Vitamin A contributes to normal iron metabolism. source↗
L4c UK NHS
Cautious
Do not take cod liver oil or any supplements containing vitamin A (retinol) when you're pregnant. Too much vitamin A could harm your baby. source↗
L4d TW TFDA / 衛福部
Neutral
維生素A 指示藥每日用量上限 10,000 IU(3,000 微克 RE);換算:1 微克 RE = 1 微克 Retinol = 6 微克 β-Carotene;3 微克 RE = 10 IU。 source↗
L4e WHO
Supportive
In settings where vitamin A deficiency is a public health problem, vitamin A supplementation is recommended in infants and children 6-59 months of age as a public health intervention to reduce child morbidity and mortality (strong recommendation). source↗
L5a NIH Office of Dietary Supplements
Supportive
The most common clinical sign of vitamin A deficiency is xerophthalmia, which develops after plasma retinol has been low. The first sign is night blindness, or the inability to see in low light or darkness as a result of low rhodopsin levels in the retina. source↗
L5c Cleveland Clinic
Cautious
One of the early signs of vitamin A deficiency is night blindness (nyctalopia). In other words, you need vitamin A to be able to see at night. As the vitamin A deficiency worsens, the whites of your eyes and your corneas can become dry and you aren't able to produce tears (xerophthalmia). Vitamin A supplements can cure night blindness and help lubricate your eyes again. However, vision loss due… source↗
L5e Specialty Society (condition-mapped)
Supportive
Vitamin A deficiency stops the production of these pigments, leading to night blindness. The change in the AREDS formulation results from the AREDS2 trial, where former smokers who took the formulation with beta-carotene had a higher incidence of lung cancer. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-vision-INT-vitamin-a-001 繁體中文版 →